Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
The Journal of Pathology
|
October 26, 2011
Immunophenotypic and genomic characterization of papillary carcinomas of the breast
Raphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 25, 2015
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
Elena Provenzano, Veerle Bossuyt, Giuseppe Viale, et al.
Nature Medicine
|
January 6, 2009
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Pierre Farmer, Hervé Bonnefoi, Pascale Anderle, et al.
Breast Cancer Research : BCR
|
April 10, 2007
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
Anne Vincent-Salomon, Nadège Gruel, Carlo Lucchesi, et al.
The American Journal of Pathology
|
August 4, 2018
Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression
Pierre Romero, Vanessa Benhamo, Gabrielle Deniziaut, et al.
Breast Cancer Research and Treatment
|
June 30, 2010
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
François Bertucci, Nathalie Borie, Henri Roche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2008
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
Giuseppe Viale, Anita Giobbie-Hurder, Meredith M Regan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 13, 2018
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
Sabrina Croce, Agnès Ducoulombier, Agnès Ribeiro, et al.
Breast Cancer Research and Treatment
|
October 24, 2015
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
Meredith M Regan, Olivia Pagani, Prudence A Francis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 30, 2018
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
Bérengère Dadone-Montaudié, Laurent Alberti, Adeline Duc, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
The Journal of Pathology
|
October 26, 2011
Immunophenotypic and genomic characterization of papillary carcinomas of the breast
Raphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 25, 2015
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
Elena Provenzano, Veerle Bossuyt, Giuseppe Viale, et al.
Nature Medicine
|
January 6, 2009
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Pierre Farmer, Hervé Bonnefoi, Pascale Anderle, et al.
Breast Cancer Research : BCR
|
April 10, 2007
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
Anne Vincent-Salomon, Nadège Gruel, Carlo Lucchesi, et al.
The American Journal of Pathology
|
August 4, 2018
Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression
Pierre Romero, Vanessa Benhamo, Gabrielle Deniziaut, et al.
Breast Cancer Research and Treatment
|
June 30, 2010
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
François Bertucci, Nathalie Borie, Henri Roche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2008
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
Giuseppe Viale, Anita Giobbie-Hurder, Meredith M Regan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 13, 2018
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors
Sabrina Croce, Agnès Ducoulombier, Agnès Ribeiro, et al.
Breast Cancer Research and Treatment
|
October 24, 2015
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
Meredith M Regan, Olivia Pagani, Prudence A Francis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 30, 2018
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
Bérengère Dadone-Montaudié, Laurent Alberti, Adeline Duc, et al.
Page
of 8